Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that is clinically used to evaluate and stimulate natural growth hormone production. As a truncated form of GHRH, Sermorelin preserves the essential region responsible for stimulating the pituitary gland. Beyond its clinical applications, it has gained research interest for its potential to enhance bone density, reduce scar formation, mitigate cognitive decline associated with dementia, and decrease seizure activity.